Baseline incidence and severity of renal insufficiency evaluated by estimated glomerular filtration rates in patients scheduled for contrast-enhanced CT

Acta Radiologica

Volumn 52, Issue 5, 2011, Pages 581-586

  Utsunomiya, Daisuke ^a   Yanaga, Yumi ^a   Awai, Kazuo ^b   Oda, Seitaro ^a   Funama, Yoshinori ^a   Namimoto, Tomohiro ^a   Yamashita, Yasuyuki ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b HIROSHIMA UNIVERSITY   (Japan)

Author keywords

Adults; Complications; Contrast agents intravenous; CT

Indexed keywords

ADULTS; CARDIOVASCULAR DISEASE; CHRONIC LIVER DISEASE; COMPLICATIONS; CONTRAST AGENTS-INTRAVENOUS; CONTRAST-ENHANCED CT; CT; DIABETES MELLITUS; GLOMERULAR FILTRATION RATE; MEAN AGES; MULTI VARIATE ANALYSIS; NEPHROPATHY; RENAL FUNCTIONS; RISK FACTORS; UNIVARIATE ANALYSIS;

MULTIVARIANT ANALYSIS;

RISK PERCEPTION;

CONTRAST MEDIUM;

ADOLESCENT; ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; COMPUTER ASSISTED TOMOGRAPHY; DIABETES MELLITUS; FEMALE; GLOMERULUS FILTRATION RATE; HOSPITALIZATION; HUMAN; INCIDENCE; KIDNEY FAILURE; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; RETROSPECTIVE STUDY; STATISTICAL MODEL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARDIOVASCULAR DISEASES; CONTRAST MEDIA; DIABETES MELLITUS; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; INCIDENCE; LOGISTIC MODELS; MALE; MIDDLE AGED; RENAL INSUFFICIENCY; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TOMOGRAPHY, X-RAY COMPUTED;

EID: 80051557578     PISSN: 02841851     EISSN: 16000455     Source Type: Journal    
DOI: 10.1258/ar.2011.100395     Document Type: Article

References (31)

1. McCullough PA, Wolyn R, Rocher LL, et al. Acute renal failure after coronary intervention: Incidence, risk factors, and relationship to mortality. Am J Med 1997;103:368-75
2. Fishman EK, Reddan D. What are radiologists doing to prevent contrast-induced nephropathy (CIN) compared with measures supported by current evidencê A survey of European radiologists on CIN associated with computed tomography. Acta Radiol 2008;49:310-20
3. Katzberg RW, Lamba R. Contrast-induced nephropathy after intravenous administration: Fact or fiction? Radiol Clin North Am 2009;47:789-800, v
4. Katzberg RW, Newhouse JH. Intravenous contrast medium-induced nephrotoxicity: Is the medical risk really as great as we have come to believê Radiology 2010;256:21-8
5. Thomsen HS, Morcos SK, Erley CM, et al. The ACTIVE Trial: Comparison of the effects on renal function of iomeprol-400 and iodixanol-320 in patients with chronic kidney disease undergoing abdominal computed tomography. Invest Radiol 2008;43:170-8
6. Moore RD, Steinberg EP, Powe NR, et al. Nephrotoxicity of high-osmolality versus low-osmolality contrast media: Randomized clinical trial. Radiology 1992;182:649-55
7. Berg KJ. Nephrotoxicity related to contrast media. Scand J Urol Nephrol 2000;34:317-22
8. Becker CR, Reiser MF. Use of iso-osmolar nonionic dimeric contrast media in multidetector row computed tomography angiography for patients with renal impairment. Invest Radiol 2005;40:672-5
9. Nguyen SA, Suranyi P, Ravenel JG, et al. Iso-osmolality versus low-osmolality iodinated contrast medium at intravenous contrast-enhanced CT: Effect on kidney function. Radiology 2008;248:97-105
10. Thomsen HS, Morcos SK. Risk of contrast-medium-induced nephropathy in high-risk patients undergoing MDCT-a pooled analysis of two randomized trials. Eur Radiol 2009;19:891-7
11. Barrett BJ, Parfrey PS. Clinical practice. Preventing nephropathy induced by contrast medium. N Engl J Med 2006;354:379-86
12. Morcos SK, Thomsen HS, Webb JA. Contrast-media-induced nephrotoxicity: A consensus report. Contrast Media Safety Committee, European Society of Urogenital Radiology (ESUR). Eur Radiol 1999;9:1602-13
13. Elicker BM, Cypel YS, Weinreb JC. IV contrast administration for CT: A survey of practices for the screening and prevention of contrast nephropathy. Am J Roentgenol 2006;186:1651-8
14. Duncan L, Heathcote J, Djurdjev O, et al. Screening for renal disease using serum creatinine: who are we missinĝNephrol Dial Transplant 2001;16:1042-6
15. Herts BR, Schneider E, Poggio ED, et al. Identifying outpatients with renal insufficiency before contrast-enhanced CT by using estimated glomerular filtration rates versus serum creatinine levels. Radiology 2008;248:106-13
16. Board. NKFNKDOQIKDA. K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Am J Kidney Dis 2002;39:S1-266
17. Lameire N, Adam A, Becker CR, et al. Baseline renal function screening. Am J Cardiol 2006;98:21K-6.K.
18. Matsuo S, Imai E, Horio M, et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 2009;53:982-92
19. Abutaleb N. Why we should sub-divide CKD stage 3 into early (3a) and late (3b) components. Nephrol Dial Transplant 2007;22:2728-9
20. Ledermann HP, Mengiardi B, Schmid A, et al. Screening for renal insufficiency following ESUR (European Society of Urogenital Radiology) guidelines with on-site creatinine measurements in an outpatient setting. Eur Radiol 2010;20:1926-33
21. Tippins RB, Torres WE, Baumgartner BR, et al. Are screening serum creatinine levels necessary prior to outpatient CT examinations? Radiology 2000;216:481-4
22. Weisbord SD, Mor MK, Resnick AL, et al. Incidence and outcomes of contrast-induced AKI following computed tomography. Clin J Am Soc Nephrol 2008;3:1274-81
23. Heller CA, Knapp J, Halliday J, et al. Failure to demonstrate contrast nephrotoxicity. Med J Aust 1991;155:329-32
24. Lodhia N, Kader M, Mayes T, et al. Risk of contrast-induced nephropathy in hospitalized patients with cirrhosis. World J Gastroenterol 2009;15:1459-64
25. Yanaga Y, Awai K, Funama Y, et al. Low-dose MDCT urography: Feasibility study of low-tube-voltage technique and adaptive noise reduction filter. Am J Roentgenol 2009;193:W220-9
26. Utsunomiya D, Oda S, Funama Y, et al. Comparison of standard- and low-tube voltage MDCT angiography in patients with peripheral arterial disease. Eur Radiol 2010;20:2758-65
27. Heinrich MC, Haberle L, Muller V, et al. Nephrotoxicity of iso-osmolar iodixanol compared with nonionic low-osmolar contrast media: Meta-analysis of randomized controlled trials. Radiology 2009;250:68-86
28. Tepel M, van der Giet M, Schwarzfeld C, et al. Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. N Engl J Med 2000;343:180-4
29. Kuhn MJ, Chen N, Sahani DV, et al. The PREDICT study: A randomized double-blind comparison of contrast-induced nephropathy after low- or isoosmolar contrast agent exposure. Am J Roentgenol 2008;191:151-7
30. Barrett BJ, Katzberg RW, Thomsen HS, et al. Contrast-induced nephropathy in patients with chronic kidney disease undergoing computed tomography: A double-blind comparison of iodixanol and iopamidol. Invest Radiol 2006;41:815-21
31. Lencioni R, Fattori R, Morana G, et al. Contrast-induced nephropathy in patients undergoing computed tomography (CONNECT) - a clinical problem in daily practicê A multicenter observational study. Acta Radiol 2010;51:741-50